JP Morgan Rates JBS buy, $18 Price Target

JP Morgan maintains its buy rating on JBS, setting an $18 price target, a 47.30% upside from the current price.

By EarningsIQ Research Desk · Published Jun 29, 2026, 12:02 PM EDT · Updated Jul 1, 2026, 2:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

JP Morgan rated JBS N.V. ($JBS) "buy" with a $18 price target on June 29, 2026.

Since the rating, $JBS is down 0.7% after 1 week, up 16.4% after 1 month and up 6.6% to date (from the $12.22 close on Jun 29, 2026).

JBS JBS N.V.

$13.03 -0.76% year to date

Daily close · Oct 16, 2026

Key Points

JP Morgan reiterated its buy rating on JBS, setting a price target of $18 on June 29, 2026.
JP Morgan's $18 price target implies 47.30% upside from JBS N.V.'s ($JBS) current $12.22 share price.
Shares of JBS traded near $12.22 on Monday, reflecting the latest analyst action.
Several funds adjusted their positions in JBS, including BlackRock and Davis Selected Advisers.

Get $JBS trade alerts by text

We text you when insiders, Congress or big funds trade $JBS. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated JBS N.V. alert may contain errors. Disclosures

JP Morgan has reiterated its buy rating for JBS, setting a price target of $18. This action, taken on June 29, 2026, reflects the firm's continued confidence in the company's prospects.

Analyst rating track record

JP Morgan vs. the S&P 500

YTD return -2.08% hypothetical

All-time return +35.50% S&P 500 +36.60%

vs. S&P 500 -1.10% behind the index

Hypothetical returns from JP Morgan's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in JBS

Several institutional investors have been active in JBS. BlackRock, Inc. increased its holdings by 3,284,423 shares, bringing its total to 28,826,636 shares valued at approximately $517.7 million, marking a 12.9% increase. Davis Selected Advisers significantly boosted its position by 14,389,919 shares to a total of 26,244,660 shares, worth about $471.4 million, which is a 121.4% rise. Arrowstreet Capital, Limited Partnership also expanded its stake by 4,147,304 shares, resulting in 7,687,775 shares valued at $138.1 million, reflecting a 117.1% increase. In contrast, Ameriprise Financial Inc trimmed its position by 136,124 shares, ending with 6,704,692 shares valued at $120.4 million, a 2% decrease.

JBS N.V. Stock Up 2.2%

Shares of JBS traded near $12.22 on Monday. The stock has seen various institutional activities that could influence its future movements. Investors are closely watching how these changes, along with analyst ratings, might impact the stock's performance.

12-month forecast

$JBS price target

JBS N.V. daily closes and this analyst's $18 target. Not advice.

Insider Buying and Selling at JBS N.V.

Several insiders have been buying shares of JBS. Guilherme Perboyre Cavalcanti, the Global CFO and IRO, acquired 112,098 shares on June 9, 2026, and 185,828 shares on May 21, 2026. Additionally, Jeremiah Alphonsus O'Callaghan purchased 76,782 shares on May 21, 2026. These transactions suggest confidence from the company's leadership.

Analysts Set New Price Targets

On June 29, 2026, JP Morgan maintained its buy rating on JBS with a price target of $18. This was part of a broader trend where JP Morgan has consistently supported the stock with a buy rating over recent months. Barclays also maintained a buy rating on JBS with a higher price target of $21 on May 14, 2026.

Bottom Line

JP Morgan's reiterated buy rating and $18 price target highlight confidence in JBS's potential. Institutional moves, such as those by BlackRock and Davis Selected Advisers, further underscore interest in the stock. As always, remember that analyst ratings and institutional filings like these are backward-looking and should be considered as part of a broader investment strategy.